Recommendations were not based on cost-effectiveness of options. Patient preferences were not discussed. Background papers providing critical appraisal of the evidence and tentative recommendations prepared by the chapter author were pre-circulated to the members. Consensus was reached on final recommendations. 3 cohort studies provide evidence of improved pregnancy-related outcomes with screening and erythromycin therapy.
Economic evaluations support screening under certain conditions.
Sensitivity analysis showed that probability of developing PID and test cost were most important to cost savings. Citations in support of individual recommendations are identified in the guideline text. This report was externally peer-reviewed. The Canadian Expert Interdisciplinary Advisory Committee on Sexually Transmitted Diseases in Children and Youths recommended more extensive screening, primarily aimed at diseases other than chlamydia. Sponsors The Canadian Task Force on the Periodic Health Examination developed this guideline with funding from Health Canada.